Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Purple Biotech Q3 EPS $(0.27)

Purple Biotech Q3 EPS $(0.27)

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.

byBill Haddad

November 8, 2022

1 minute read

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.

Why This UnitedHealth Analyst Sees Upside Ahead Following Q2 Earnings

By Wayne Duggan

July 15, 5:19 PM

Shares of UnitedHealth Group Inc (NYSE: UNH) rallied 5.38% on Friday after the health insurer reported a second-quarter earnings beat and hiked its full-year guidance.

UNH

Uber Likely To Post Narrower Q2 Loss; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

By Lisa Levin

August 1, 3:41 AM

Uber Technologies, Inc. (NYSE: UBER) is expected to report its second quarter financial results, before the opening bell on Aug. 1, 2023.

UBER

Stephens & Co. Maintains Overweight on BellRing Brands, Raises Price Target to $37

By Benzinga Newsdesk

February 8, 8:40 AM

Stephens & Co. analyst Ben Bienvenu maintains BellRing Brands (NYSE:BRBR) with a Overweight and raises the price target from $35 to $37.

BRBR

Earnings

Amedisys’s Return On Capital Employed Overview

By Benzinga Insights

May 10, 10:52 AM

According to Benzinga Pro, during Q1, Amedisys (NASDAQ:AMED) earned $24.91 million, a 21.04% increase from the preceding quarter.…

AMED

Purple Biotech Q3 EPS $(0.27)

Related Posts

Why This UnitedHealth Analyst Sees Upside Ahead Following Q2 Earnings

Uber Likely To Post Narrower Q2 Loss; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

Stephens & Co. Maintains Overweight on BellRing Brands, Raises Price Target to $37

Amedisys’s Return On Capital Employed Overview